Repositorio Dspace

Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?

Mostrar el registro sencillo del ítem

dc.contributor.author Navarro-Zaragoza, Javier
dc.contributor.author Cuenca-Bermejo, Lorena
dc.contributor.author Almela-Rojo, Pilar
dc.contributor.author Laorden, María-Luisa
dc.contributor.author Herrero, María-Trinidad
dc.date.accessioned 2025-11-24T15:11:51Z
dc.date.available 2025-11-24T15:11:51Z
dc.date.issued 2021-03
dc.identifier.citation Navarro-Zaragoza J, Cuenca-Bermejo L, Almela P, Laorden ML, Herrero MT. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease? IJMS. 16 de marzo de 2021;22(6):3038.
dc.identifier.issn 1661-6596
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22313
dc.description.abstract Small heat shock proteins (HSPs), such as HSP27, are ubiquitously expressed molecular chaperones and are essential for cellular homeostasis. The major functions of HSP27 include chaperoning misfolded or unfolded polypeptides and protecting cells from toxic stress. Dysregulation of stress proteins is associated with many human diseases including neurodegenerative diseases, such as Parkinson's disease (PD). PD is characterized by the presence of aggregates of ?-synuclein in the central and peripheral nervous system, which induces the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and in the autonomic nervous system. Autonomic dysfunction is an important non-motor phenotype of PD, which includes cardiovascular dysregulation, among others. Nowadays, the therapies for PD focus on dopamine (DA) replacement. However, certain non-motor symptoms with a great impact on quality of life do not respond to dopaminergic drugs; therefore, the development and testing of new treatments for non-motor symptoms of PD remain a priority. Since small HSP27 was shown to prevent ?-synuclein aggregation and cytotoxicity, this protein might constitute a suitable target to prevent or delay the motor and non-motor symptoms of PD. In the first part of our review, we focus on the cardiovascular dysregulation observed in PD patients. In the second part, we present data on the possible role of HSP27 in preventing the accumulation of amyloid fibrils and aggregated forms of ?-synuclein. We also include our own studies, highlighting the possible protective cardiac effects induced by L-DOPA treatment through the enhancement of HSP27 levels and activity.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.subject.mesh Animals
dc.subject.mesh HSP27 Heat-Shock Proteins/chemistry/metabolism
dc.subject.mesh Humans
dc.subject.mesh Parkinson Disease/drug therapy/physiopathology
dc.subject.mesh Protein Aggregates
dc.subject.mesh Protein Binding
dc.subject.mesh alpha-Synuclein/metabolism
dc.title Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 33809767
dc.relation.publisherversion https://www.mdpi.com/1422-0067/22/6/3038
dc.identifier.doi 10.3390/ijms22063038
dc.journal.title International Journal of Molecular Sciences
dc.identifier.essn 1422-0067


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional  Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta